Antiplatelet agents for preventing vaso-occlusive events in people with sickle cell disease: a systematic review.

Sickle cell disease (SCD) is the most common hemoglobinopathy, occurring worldwide, and vaso-occlusive events (VOEs) are its paramount, hallmark clinical manifestation. Evidence exists that platelets play an important role in generating VOEs.